1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis program supports early-stage clinical trial applications that inform early-stage technology development, aligning with NIBIB's mission-focused program areas. NIBIB will only support feasibility, Phase I, first-in-human, safety, or other small clinical trials.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities; Nonprofits; State/local governments; Small businesses; For-profit organizations. Confirm the full requirements in the official notice before applying.
The current listing shows varies (R21 Exploratory/Developmental grants typically fund up to $275,000 total over two years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
National Institute of Biomedical Imaging and Bioengineering (NIBIB) SBIR/STTR Program is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH). The NIBIB Small Business Program supports the development and integration of advanced biomedical imaging, bioengineering, sensing, and computational technologies. This includes novel medical device platforms, bio-electromagnetic technologies, health informatics (including digital health, mobile health, and telehealth), and diagnostic and therapeutic technologies.
NIBIB Biomedical Technology Resource Centers (P41) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH). This FOA encourages grant applications for Biomedical Technology Resource Centers (BTRCs) that conduct research and development on new technologies driven by the needs of basic, translational, and clinical researchers.
The NIBIB Trailblazer Award is an enhanced R21 mechanism for New and Early Stage Investigators (NIs/ESIs) to pursue research at the interface of life sciences with engineering and physical sciences — explicitly including artificial intelligence, machine learning, and deep learning for medical imaging and biomedical data analysis. Trailblazer projects receive up to $400,000 in direct costs over three years, and NIBIB encourages applications in computational imaging, AI-driven diagnostic algorithms, deep learning for medical image segmentation and classification, machine learning approaches to biomedical signal processing, and AI for digital pathology, radiology, and wearable health sensors. Beginning FY2026, NIH funding opportunities are posted exclusively on Grants.gov rather than the NIH Guide. Trailblazer complements NIBIB's standard R21 (capped at $275,000 over two years) and R01 pathway for larger established research programs.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read article